Resistentia Pharmaceuticals AB

Resistentia Pharmaceuticals AB is a biotechnology company focusing on the development of innovative immunotherapies. The Company’s lead project is an immunotherapy for the treatment of allergy/asthma. Building on over 10 years of academic research, Resistentia was founded in 1998. Since then, the Company has developed an industrial organization consisting of 25 people, comprising management and practical experience from all areas of pre-clinical and clinical development of biopharmaceuticals.